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Background: We present here the oncological and functional outcomes of limb salvage with or without reconstruction for primary 
sarcomas in the pelvic bone.
Methods: Forty-four patients who underwent pelvic resection for primary sarcomas involving the pelvis were reviewed. The 
average follow-up period was 39 months (range, 0 to 146 months). Chondrosarcoma (n = 17) and osteosarcoma (n = 10) were 
the most common diagnoses. Various clinicopathologic factors were analyzed in relation to the oncological outcomes of overall 
survival and local recurrence. The Musculoskeletal Tumor Society functional scores and complications were compared according to 
the tumor location, pelvic continuity and the type of resection.
Results: The overall 5-year survival rate was 40%. Metastasis at the time of diagnosis, the surgical margin and the histologic 
grade were the independent prognostic factors for survival. The surgical margin was an independent prognostic factor for local 
recurrence. An ischiopubic location of the tumor, restoration of pelvic continuity and hip joint reconstruction with total hip 
replacement arthroplasty were related with higher functional scores. Complications occurred in 50% of the patients and the 
complications varied according to the tumor location with infection being the most common complication.
Conclusions: Achieving an adequate surgical margin is necessary for improving the oncological outcome of pelvic sarcomas. 
Restoration of the pelvic continuity and the hip joint improves the functional outcome. However, complications are common and so 
careful selection of the reconstruction method is needed.
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Primary pelvic sarcomas are difficult to surgically treat 
because of the anatomic proximity of the pelvis to many 
neurovascular structures and the urinary and intestinal 
tracts. In addition, extensive resection of pelvic sarcomas 
oft  en necessitates reconstruction to avoid severe functional 
disabilities from the impairment of the load-bearing 
axis.
1,2) Therefore, decisions on the surgical treatment 
of pelvic sarcomas should be based on consideration in 
terms of both the resection and reconstruction, with the 
primary treatment goal being complete tumor resection 
and the secondary goal being preservation of the lower 
limb function.
3) Limb-salvage surgery has currently 
become a possible option for many patients due to the 
advances in adjuvant treatments such as chemotherapy 
and radiation therapy. In addition, the developments in 
imaging techniques have allowed accurate visualization 
of the tumor extent and this helps to perform appropriate 
surgical resection.
4,5) 
Different reconstruction techniques that result in 
a variety of functional outcomes and complications are 
performed according to the anatomical location and the 
extent of resection of pelvic tumors. Since the adoption 
of the limb-salvage techniques for the treatment of pelvic 
sarcomas, arthrodesis or pseudoarthrosis techniques 161
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have been used for reconstruction.
6-9) Allograft  s, recycled 
autograft  s,
7) bone cement
10) and tumor prostheses
4,9) have 
recently been employed in proper combinations to obtain 
joint mobility. Likewise, various surgical techniques have 
been attempted to improve the patients’ quality of life 
by the reducing the bed rest time and promoting early 
ambulation. 
In this study, we assessed the oncological outcomes 
and prognostic factors of limb-salvage surgery and we 
analyzed the functional outcomes and complications ac-
cording to the location and extent of resection in patients 
with primary pelvic sarcomas.
METHODS
Forty-four patients who had been surgically treated for 
primary sarcomas of the pelvis between October 1991 
and December 2006 were included in this study. There 
were 18 males and 26 females with a mean age of 39 
years (range, 11 to 74 years). Five of them had undergone 
surgical treatment before being admitted to our institution 
for relapse. Metastasis was noted in 7 patients at the time 
of diagnosis. According to Enneking’s classification,
11) 
1 patient had a stage IA tumor, 9 had stage IB tumors, 
1 had a stage IIA tumor, 26 had stage IIB tumors and 
7 had stage III tumors. The histological diagnosis was 
chondrosarcoma in 17 patients, osteosarcoma in 10, 
malignant fi  brous histiocytoma in 6, Ewing sarcoma in 3, 
synovial sarcoma in 3, giant cell tumor in 2, liposarcoma 
in 1, malignant peripheral nerve sheath tumor in 1 and 
undifferentiated sarcoma in 1. The histological grade 
was low in 10 patients, high in 33 and unidentified in 1 
patient. Soft tissue sarcoma involving bone structures 
was observed in 7 patients (3 patients with a synovial 
sarcoma, 2 patients with a malignant fi  brous histiocytoma, 
1 patient with a liposarcoma and 1 patient with a malig-
nant peripheral nerve sheath tumor). The tumor size 
was measured as the maximum diameter on the MRI or 
pathological examination, and the average tumor size 
was 9.9 cm (range, 3.5 to 25.0 cm). The surgical margin 
was wide in 25 patients, marginal in 8 and intralesional in 
11. Adjuvant therapies were carried out according to the 
histological diagnosis and the tumor stage. Preop  eratively, 
chemotherapy was done in 12 patients and radi  ation 
therapy was done in 2 patients. Postoperatively, chemo-
therapy was done in 13 patients, radiation therapy was 
done in 9 and both were done in 3. Th   e mean follow-up 
period was 39 months (range, 0 to 146 months) and the 
survivors were followed up for an average of 61 months 
(range, 12 to 146 months). 
The locations of the tumors were classified into 3 
types based on a modification of the system established 
by Enneking and Dunham.
11) The iliosacral type was 
defined as a tumor involving the ilium or the sacrum 
and not the acetabulum, the actabular type was defined 
as the one invading the acetabulum and the ischiopubic 
type was defi  ned as a tumor involving the pubis and not 
the acetabulum in this study. There were 20 tumors of 
the iliosacral type, 19 tumors of the acetabular type and 5 
ischiopubic type tumors.
The reconstruction techniques were determined 
according to the anatomical location of the sarcoma 
and the presence or absence of continuity of the load-
bearing axis extending from the sacrum to the femur 
(Table 1). Continuity was disrupted aft  er tumor resection 
for 9 of the 19 iliosacral type tumors and for 16 of the 19 
acetabular type tumors. Reconstruction was performed 
for 7 iliosacral type tumors and for 17 acetabular type 
tumors. Reconstruction was not carried out despite the 
absence of continuity aft  er resection in 4 patients who had 
Table 1. Pelvic Sarcomas: Surgical Procedures 
  Resection type Reconstruction
Iliosacral 20
    Continuity (+) 11 10 None
  1 Bone cementization
    Continuity (-)   9   2 None
  3 Pasteurization & bone cementization
  1 Bone cementization
  2 Arthrodesis with pasteurization
  1 Galvestone operation
Acetabular 19
    Continuity (+)   3   3 Bone cementization
    Continuity (-) 16   2 None
  8 Pasteurization & THRA
  5 Saddle prosthesis
  1 Pasteurization
Ischiopubic   5
    Continuity (+)   5   5 None
Total 44
THRA: Total hip replacement arthroplasty.162
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had a poor general condition preoperatively. All of the 
patients with ischiopubic type tumors underwent tumor 
resection without reconstruction. Of the patients with the 
acetabular type tumors, those with the absence of pelvic 
ring continuity after tumor resection were reconstructed 
with a composite reconstruction using low-heat treated 
recycled autograft  s and hip replacement arthroplasty with 
bone cement augmentation,
12) or with a saddle prosthesis. 
Pelvic ring continuity was restored or maintained after 
reconstruction in 40 patients.
The overall survival rate and the local recurrence 
rate were calculated for the assessment of the oncological 
results. Th   e associations with the histopathological factors 
were examined using the Kaplan-Meier method and the 
Cox proportional hazards model. The functional results 
were evaluated according to the Musculoskeletal Tumor 
Society (MSTS) scoring system
13) which assigns 0 to 5 
points for each of the following categories: pain, function, 
emotional acceptance, use of supports, walking ability 
and gait. Except for the 11 patients whose records were 
not available, 33 patients were included in the assessment 
of the functional results. The absence or presence of 
continuity of the pelvic ring was assessed on 2 occasions, 
once after resection and then after reconstruction, and 
the patients were subdivided according to the presence 
of continuity of the pelvic ring on each occasion. The 
MSTS scores of the patients grouped according to the 
presence of continuity of the pelvic ring, the kind of 
the inserted implants and the anatomical location of 
the tumor were compared. The associations between 5 
major complications (local wound problems, implant 
failure, nerve injury, internal organ damage and vascular 
problems) and the anatomical location of the tumor 
and the continuity of the pelvic ring after surgery were 
evaluated.
RESULTS
Oncological Results
Overall, 22 patients died until the last follow-up and the 
mean 5-year overall survival rate, which was calculated 
using the Kaplan-Meier method, was 40% (± 9%) for the 
43 patients, with excluding 1 patient who was not available 
for follow-up. Of the 21 survivors, 18 had no evidence of 
disease and 3 were alive with disease. Twenty patients died 
due to the consequences of metastasis or local recurrence, 
1 patient died due to intra  operative hemorrhage and 1 
patient died due to sepsis during chemotherapy. Th  e  mean 
interval from surgery to death was 20 months (range, 0 to 
55 months). Th   e age, the presence of metastasis at the time 
of diagnosis, the histological grade and the surgical margin 
were shown to have statistically significant relationships 
with the survival rate on the analysis using the Kaplan-
Meier method (Table 2). The Cox multivariable analysis 
revealed that metastasis at the time of diagnosis, the 
Table 2. Univariate Analysis for Overall Survival
Clinicopathologic factors Patients Overall survival p-value
Sex Male 17   33.4 ± 12.8 0.4851
Female 25   46.7 ± 11.9
Age < 40 yr 20   60.6 ± 12.0 0.0389
≥ 40 yr 22   19.9 ± 11.2
Metastasis at 
  diagnosis Absent 37 44.6 ± 1.0 0.002
Present   6   16.7 ± 15.2
Histologic grade Low   9   87.5 ± 11.7 0.0392
High 32 29.9 ± 9.1
Histologic type Bone sarcoma 35 47.9 ± 9.4 0.1784
Soft tisue 
  sarcoma   7   0.0 ± 0.0
Location Ischiopubic   6   66.7 ± 27.2 0.1109
Others 36 37.2 ± 9.0
Tumor size < 8 cm 22   49.5 ± 13.2 0.1481
≥ 8 cm 17   22.2 ± 12.4
Surgical margin Wide 24   53.0 ± 12.1 0.0115
Others 18   25.8 ± 12.1
Referral pattern Fresh 35   53.0 ± 12.1 0.4733
Recurred   5   25.8 ± 12.1
Table 3. Mutivariate Analysis for Overall Survival
Factors
Overall survival
p-value Relative 
risk
95% Conﬁ  dence 
interval
Metastasis at diagnosis Absent   1 0.005
Present 10.4   2.1-52.7
Histologic grade Low   1 0.047
High   8.6   1.0-71.6
Surgical margin Wide   1 0.025
Others   2.9 1.1-7.2163
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histological grade and the surgical margin were the 
independent prognostic factors (Table 3).
Local recurrence was identifi  ed in 20 patients until 
the last follow-up. The mean 5-year local recurrence-
free survival rate was 45% (± 9%) in the 42 patients, with 
excluding 1 patient who was unavailable for follow-up 
and excluding another 1 who had died of intraoperative 
hemorrhage. The Kaplan-Meier analysis showed that the 
surgical margin had a statistically significant correlation 
with local recurrence (Table 4) and it was identifi  ed as an 
independent prognostic factor on the Cox multivariable 
analysis (Table 5).
Functional Results
Th   e mean MSTS score was higher in the patients with the 
presence of continuity of the pelvic ring after resection 
(75.4%) than in those with the absence of the continuity 
(65.8%). The score was also higher in the patients with 
continuity that was restored via reconstruction after re-
section than in those with the absence of continuity (Fig. 1). 
Th   e mean functional score was higher in the patients with 
the ischiopubic type tumors (83.9%) than in those with the 
acetabular type tumors (64.8%) or those with the iliosacral 
type tumors (70.5%). Of the patients with the acetabular 
type tumors, the mean MSTS score was higher in the total 
hip replacement arthroplasty group (74.4%) than that in 
the saddle prosthesis group (63.3%).
Complications
Overall, 26 major complications occurred in 22 patients 
(50%). The incidence of complications was 40% in the 
patients with iliosacral type tumors (10 in 8 patients), 
58% in the patients with acetabular type tumors (13 in 
11 patients) and 60% in the patients with ischopubic type 
tumors (3 in 3 patients). Th   e most common complications 
were related with wound healing such as an infection (9 
cases) (Table 6). Implant failure and internal organ damage 
were the most common complications in the patients 
with acetabular type tumors and ischiopubic type tumors, 
respectively. Th   e incidence of complications was higher in 
the patients in which resection resulted in the loss of pelvic 
continuity than those patients in which resection did not 
Table 4. Univariate Analysis for Local Recurrence
Clinicopathologic factors Patients
Local 
recurrence-
free survival
p-value
Sex Male  17 29.4 ± 13.4 0.4067
Female  25 56.8 ± 10.5
Age < 40 yr 20 56.4 ± 11.9 0.1107
≥ 40 yr 22 35.0 ± 13.1
Tumor size < 8 cm 22 55.2 ± 11.4 0.3197
≥ 8 cm 17 25.7 ± 13.9
Histologic grade Low   9 53.3 ± 17.3 0.9067
High 32 41.5 ± 10.3
Histologic type Bone sarcoma 35 44.0 ± 9.6 0.9081
Soft tissue
  sarcoma   7 57.1 ± 18.7
Location Ischiopubic   6 31.3 ± 24.5 0.6926
Others 36 47.8 ± 9.0
Surgical margin Wide 24 70.7 ± 10.4 0.0001
Others 18   0.0 ± 0.0
Referral pattern Fresh 35 39.7 ± 9.6 0.9066
Recurred   5 53.3 ± 24.8
Table 5. Mutivariate Analysis for Local Recurrence
Factors
Local recurrence-free 
survival
p-value
Relative 
risk
95% Conﬁ  dence 
Interval
Surgical margin Wide 1 0.001
Others 5.4 2.0-14.8
Fig. 1. Musculoskeletal Tumor Society functional scores according to the 
restoration of pelvic continuity.164
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result in the loss of pelvic continuity; 60% (15 patients) 
with loss of continuity and 37% (7 patients) without loss of 
continuity.
DISCUSSION
Th   e growing interest in cancer patients’ quality of life has 
led to an increase of analyzing the functional outcomes 
of oncological treatments in many orthopedic oncology 
studies. Although much progress has been made in the 
diag  nostic and treatment methods, sarcomas of the pelvis 
are more associated with a poor prognosis than are those 
of the long bones.
11,14) Sarcomas of the pelvis are usually 
detected in the late stages and they are difficult to sur-
gically treat in most cases. Massive tumor resection is un-
avoidable in such cases and a complete cure and func  tion-
al recovery aft  er resection are hard to achieve. As studies 
have shown that limb-salvage techniques and the am-
putation show no diff  erence in terms of the survival rate 
of patients with malignant bone tumors, the limb-salvage 
techniques are now being frequently used even for cases of 
advanced tumors.
14,15)
The possible prognostic factors for survival in pa-
tients with sarcomas of the pelvis include the tumor stage, 
the histological grade, the surgical margin and the tu-
mor location.
5,14-16) In this study, the histological grade, 
metastasis at the time of diagnosis (the tumor stage) and 
the surgical margin were the independent prognostic 
factors that were significantly related to survival. Older 
age was related to the low survival rate on the univariate 
analysis, but statistical significance was not found for 
that relationship on the multivariate analysis using the 
Cox proportional hazards model. The patients with soft 
tissue sarcomas had poorer results than those with bone 
sarcomas with 5 of the 7 patients dead, but the diff  erence 
between the two was not statistically signifi  cant. Th  ese  two 
factors might turn out to be signifi  cant prognostic factors 
for survival in future studies that will have a larger number 
of patients.
The local recurrence rate of this study was 45%, 
which is higher than that reported in most studies. We 
attributed this to the fact that a wide surgical margin 
could not be obtained in many cases of this study, with 
considering that the surgical margin was the factor most 
closely related to the local recurrence, as was also shown 
in other studies.
1,5,15,17) According to O'Connor and Sim
18) 
iliosacral type tumors had the highest local recurrence 
rate. Yet in this study, the local recurrence rate and the 
tumor location did not appear to be related to each other. 
The pelvis functions as the axis that transmits the 
weight of the upper body to the legs and the pelvis con-
tains the hip joint. If bone stock loss occurs due to wide 
resection of sarcomas, then the focus of the treatment 
should be set on restoring femorosacral continuity for 
weight bearing and obtaining mobility of the hip joint.
1,8) 
In this study, satisfactory functional results could be 
achieved in those cases where pelvic ring continuity 
was re  stored through reconstruction. The patients with 
ischiopubic type tumors had higher functional scores than 
those patients with iliosacral and acetabular type tumors. 
It is believe that the sacrum or ischium had a lesser role in 
weight bearing and accordingly their loss did not produce 
notable diff  erences. 
Restoration of hip joint mobility results in more 
satisfying functional outcomes than the pseudoarthrosis 
technique or amputation does, although it is associated 
with higher complication rates.
1,5,8,17,19) We attempted to 
restore hip joint mobility in most of the cases with ac  e  tab-
ular involvement and we found that total hip replacement 
arthroplasty resulted in higher functional scores than 
inserting a saddle prosthesis did. It is our understanding 
that when most of the proximal ilium is removed, a tumor 
prosthesis cannot be fixed and then inserting a saddle 
prosthesis, which is associated with inherent instability, 
would be the only remaining option. In contrast, when 
most of the proximal ilium is preserved or the bone stock 
is restored with a low-heat treated autograft, then total 
hip replacement arthroplasty would be applicable and 
encouraging postoperative outcomes in terms of stability 
and function would be attained.
The increased use of a tumor prosthesis in pelvic 
reconstruction combined with the prolonged survival of 
patients with sarcomas has led to a rise in the prevalence 
of a variety of prosthesis-related problems such as an 
Table 6. Complications in 44 Patients
    Location Continuity after 
resection
Complication
I II III IV V
Iliosacral 10 Maintained   5   2 1 2
Disrupted   5   2 2 1
Acetabular 13 Disrupted 13   7 6
Ischiopubic   3 Maintained   3 2 1
Total 26 26 11 6 3 4 2
I: Local wound problem - infection, impaired wound healing, II: Implant failure 
- loosening, dislocation, III: Nerve injury, IV: Internal organ damage - bowel, 
bladder, V: Vascular problem.165
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infection and loosening of the prosthesis.
20) Besides, as 
most high grade pelvic sarcomas carry a poor prognosis, 
there is controversy over the extent of surgery, and strict 
indications for surgery have been applied due to the high 
complication rates.
2,14,20-22)
Th   e complication rate in this study was 50%, which 
was similar to the 50 to 60% shown in other studies.
2,14,20-22) 
The postoperative complication rates were related to the 
extent of surgery. Particularly, complications were prev-
alent in those cases where continuity of the pelvis was lost 
during resection. In our opinion, this was attributable to 
the extensive resection and reconstruction. The tumor 
location and the type of complication appeared to be 
related: nerve damage and bowel injury were common in 
the iliosacral type tumor, every kind of complication was 
observed aft  er the use of a prosthesis in the acetabular type 
tumor and bladder injury was notable for the ischiopubic 
type tumor. Therefore, when an extensive operation is 
necessary, careful preoperative planning according to 
the tumor location would be helpful in reducing the 
complication rates.
In conclusion, achieving an adequate surgical 
mar  gin is important for increasing the survival rate and 
reducing local recurrence in patients with primary pelvic 
sarcomas. Restoration of both the pelvic continuity and the 
hip joint results in better functional outcomes. However, 
complications are common and so careful selection of a 
reconstruction method is advised.
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